Skip to content 
Man given first dose as Phase-I human clinical trial of Covaxin begins at AIIMS Delhi
In a recent development, The phase-I human clinical trial of India’s first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS here on Friday with the first dose of the injection given to a man, who is in his 30s. Over 3,500 volunteers have registered themselves for the trial at AIIMS since last Saturday, … Read more
